AstraZeneca to boost US R&D with US$3.5bn investment
BRITISH pharmaceutical giant AstraZeneca is investing US$3.5bn into expanding its research and de...
BRITISH pharmaceutical giant AstraZeneca is investing US$3.5bn into expanding its research and de...
RESEARCHERS from SINTEF have developed a “simpler” low-cost carbon capture and storage (CCS) syst...
THE NHS is set to benefit from an increased supply of oncology and autoimmune disease treatments ...
MODERNA has won the latest round of its long-running legal battle with Pfizer and its German part...
MULTINATIONAL pharmaceutical company Merck will buy Prometheus Biosciences for about US$10.8bn, a...
BIONTECH has signed a collaboration agreement with Matinas BioPharma to advance formulations for ...
A STOCKPILE of Ebola vaccine has been established by humanitarian organisations to help better pr...
FOLLOWING three highly-encouraging Covid-19 vaccine trials, the light at the end of the tunnel su...
A WORKFLOW has been developed that allows for high precision manufacturing of active pharmaceutic...
JAPAN’S Takeda Pharmaceutical has revealed it is considering a bid for Ireland’s Shire as it seek...
A STUDY has shown that near-infrared chemical imaging (NIR CI) can be used for monitoring the mix...
A NEW method has been developed to help drug developers weed out compounds that could potentially...
ROCHE has agreed a deal to buy oncology drug company Ignyta for US$27/share, a total of US$1.7bn.
Coalition seeks sustainable vaccine development
Distributor Flynn Pharma also fined
Catch up on the latest news, views and jobs from The Chemical Engineer. Below are the four latest issues. View a wider selection of the archive from within the Magazine section of this site.